Toward innovation in bioanalysis: from operational excellence to process insight

Future Science

July 2013

Recently, a major pharmaceutical company mentioned that it had two sites in different parts of the world running bioanalytical assays (BA); both sites said that their data handling processes were governed by US FDA guidelines and had been subject to recent regulatory audits. However, processes at each site appeared to be completely different.

Read the article here »